RIGHT: Rhythm ID Going Head-to-Head Trial

Completed · Phase 4

Conditions studied: Tachycardia

In brief

RIGHT is a randomized, prospective, two-arm study that will assess the differential efficacy of VITALITY 2 implantable cardioverter defibrillators (ICDs) using Rhythm ID™ versus selected Medtronic ICDs.

Key facts

Study ID

NCT00148954

Run by

Boston Scientific Corporation

People needed

1962

Starts

2005-07-01

Expected to finish

2010-07-01

Last updated by the study team

2012-01-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who meet current indications for an ICD
• Patients who sign and date a Patient Informed Consent form prior to the implant visit
• Patients who remain in the clinical care of the enrolling physician in approved centers
• Patients who are able to tolerate ICD programming as specifically prescribed in the study protocol

You may not qualify if…

• Patients who are in third degree heart block
• Patients whose life expectancy is less than 12 months
• Patients who have other cardiac surgeries or procedures planned but not yet performed during the duration of the study
• Patients who are currently enrolled in another investigational study or registry that would directly impact the treatment or outcome of the current study
• Patients who are younger than 18 years of age
• Patients who are mentally incompetent and cannot sign a Patient Informed Consent form or comply with the study
• Patients who are pregnant or plan to become pregnant during the study

Where it is running

• Medical University of South Carolina — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.